As the film title says, director Matt Embry is "living proof" that there are effective alternatives to fighting Multiple Sclerosis than conventional pharmaceuticals, but you won't hear his inspirational story from Big Pharma or research corporations like the Multiple Sclerosis Society of Canada.
At 18, Embry was diagnosed with MS. Shortly after, his father, Ashton Embry Ph.D, dedicated himself to finding answers in scientific literature. When he discovered a link between MS and nutrition, his son eventually began to show great progress in fending off the incurable disease. But when his father shared his promising medical treatment to the Multiple Sclerosis Society of Canada, the nation's largest MS research company, they didn't want to hear it. Strange -- especially when Matt Embry doesn't show any symptoms of the disease -- even to this day, twenty-two years later.
Living Proof is a heartfelt film that follows the director's journey of coming to terms with his looming infliction. It's also an engaging exposé that shines the spotlight on what appears to be corporate collusion to continue to profit on the sick (i.e. MS patients are kept in the dark about cheaper medical alternatives and encouraging experimental treatments are tied up in FDA bureaucracy).
In the Q&A, Matt Embry emphasized that he's not a doctor or researcher, he's just advocating for change. "I believe that the Multiple Sclerosis Society of Canada is important to have. They have programs that are supporting people. The question is: What can that change look like? That's what we're trying to get to."
Living Proof currently has no release date.
To learn more, visit Matt Embry's website MSHope.com.
Trailer
This film is about Matt and his journey combatting MS with nutrition and exercise. However, it also addresses other non-pharmacological issues that may reduce symptoms of MS such as CCSVI and stem cell therapy (the less invasive method).
ReplyDeleteWell-respected and published physicians, Drs. Ebers and Dake, discuss the sometimes negative control the pharmacological industry has on research. Joan & Jeff Beal outline their experience in receiving CCSVI treatment. This movie is critical of the MS society for supporting industry more than advocating for patients. It presents data on how little of the money donated to the MS society goes to research. It will be interesting to see how the MS society responds to this movie.
This film will bring the issues that many of us with MS are aware of to a wider audience. The film remains compelling; it tells a story.